| Name | Title | Contact Details |
|---|
UHC, based in Oak Brook, Ill., and representing 0.7 of the academic medical centers in the United States, is an alliance of 84 academic medical centers and 80 associate members.
Diplomat is the nation`s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. We build solutions for today`s issues while laying the groundwork for tomorrow`s healthcare. Rooted in specialty pharmacy, our brands harness innovation to create a healthier world. These include: • Diplomat Specialty Infusion Group: Our specialty infusion services deliver treatments nationwide, but a high-touch approach makes our care personal. • Diplomat Specialty Pharmacy: We help patients across the country face complex and often rare conditions. • CastiaRx: The industry`s leading specialty benefit manager, combining full-service pharmacy benefit manager capabilities with deep specialty expertise. • EnvoyHealth: Firewalled from other Diplomat business, EnvoyHealth is a full-service healthcare solutions company using innovation and technology to help partners improve lives. At Diplomat, we are more than 2,000 professionals working together nationwide to help patients realize health, happiness, and longer, fuller lives. We stand behind our employees with exceptional benefits, continuing education, and award-winning wellness programs. We want this to be the greatest place you`ve ever worked. And we believe it will be.
Westchester Medical Center is the premier provider of advanced medical care in New York`s Hudson Valley region. The flagship of the Westchester Medical Center Health Network, this 895-bed academic hospital located in Valhalla, New York, provides local residents with acute care services - Level I trauma and burn care, organ transplants and advanced neurovascular procedures and more - found nowhere else in the region. Westchester Medical Center is the primary referral facility for other hospitals in the Hudson Valley and serves as a lifeline for more than 3.5 million people.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Vestiage, Inc. exists to cultivate healthy-aging opportunities for all men and women and to nurture those opportunities with wholesome products, people, and practices. Currently we offer multiple products through two brands: RegiMEN and Monterey Bay. We do what we do because life deserves vitality and we're excited to share with you, learn from you, and grow together.